FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281777887> ?p ?o ?g. }

• W4281777887 endingPage "433" @default.
• W4281777887 startingPage "424" @default.
• W4281777887 abstract "The meta-analysis of randomized controlled trials has illustrated that the efficacy of low-dose non-vitamin K antagonist oral anticoagulants is inferior compared with standard-dose non-vitamin K antagonist oral anticoagulants, though they are still frequently prescribed for Asian patients with non-valvular atrial fibrillation. We aimed to further investigate the efficacy and safety of low-dose non-vitamin K antagonist oral anticoagulants by carrying out a meta-analysis of all relevant randomized controlled tri- als and cohort studies.Cochrane Central Register of Controlled Trials, Embase, and MEDLINE were sys- tematically searched from the inception to September 9, 2021, for randomized controlled trials or cohorts that compared the efficacy and/or safety of low-dose non-vitamin K antagonist oral anticoagulants in Asian patients with non-valvular atrial fibrillation. The primary outcomes were stroke and major bleeding, and the secondary outcomes were mortality, intracranial hemorrhage, and gastrointestinal hemorrhage. Hazard ratios and 95% CIs were estimated using the random-effect model.Nineteen publications involving 371 574 Asian patients with non-valvular atrial fibrillation were included. Compared with standard-dose non-vitamin K antagonist oral anticoagulants, low-dose non-vitamin K antagonist oral anticoagulants showed compa- rable risks of stroke (hazard ratio, 1.18; 95% CI 0.98 to 1.42), major bleeding (hazard ratio, 1.00; 95% CI 0.83 to 1.21), intracranial hemorrhage (hazard ratio, 1.13; 95% CI 0.92 to 1.38), and gastrointestinal hemorrhage (hazard ratio, 1.07; 95% CI 0.87 to 1.31), though had a higher risk of mortality (hazard ratio, 1.34; 95% CI 1.05 to 1.71). Compared with warfarin, low-dose non-vitamin K antagonist oral anticoagulants were associated with lower risks of stroke (hazard ratio, 0.73; 95% CI 0.67 to 0.79), mortality (hazard ratio, 0.69; 95% CI 0.60 to 0.81), major bleeding (hazard ratio, 0.62; 95% CI 0.51 to 0.75), intracranial hemor- rhage (hazard ratio, 0.48; 95% CI 0.33 to 0.69), and gastrointestinal hemorrhage (hazard ratio, 0.78; 95% CI 0.65 to 0.93).Low-dose non-vitamin K antagonist oral anticoagulants were superior to warfarin, and comparable to standard-dose non-vitamin K antagonist oral anticoagu- lants considering risks of stroke, major bleeding, intracranial hemorrhage, and gastroin- testinal hemorrhage. Further, high qualified studies are warranted." @default.
• W4281777887 created "2022-06-13" @default.
• W4281777887 creator A5029305216 @default.
• W4281777887 creator A5029711969 @default.
• W4281777887 creator A5044922060 @default.
• W4281777887 creator A5055814924 @default.
• W4281777887 creator A5059683450 @default.
• W4281777887 creator A5066222509 @default.
• W4281777887 creator A5075736599 @default.
• W4281777887 date "2022-06-02" @default.
• W4281777887 modified "2023-10-01" @default.
• W4281777887 title "Low-Dose NOACs Versus Standard-Dose NOACs or Warfarin on Efficacy and Safety in Asian Patients with NVAF: A Meta-Analysis" @default.
• W4281777887 cites W1521723250 @default.
• W4281777887 cites W1948469281 @default.
• W4281777887 cites W1964435302 @default.
• W4281777887 cites W1974248672 @default.
• W4281777887 cites W1979423827 @default.
• W4281777887 cites W2024062166 @default.
• W4281777887 cites W2033102959 @default.
• W4281777887 cites W2034191886 @default.
• W4281777887 cites W2052190924 @default.
• W4281777887 cites W2055248417 @default.
• W4281777887 cites W2066684490 @default.
• W4281777887 cites W2078576058 @default.
• W4281777887 cites W2097854437 @default.
• W4281777887 cites W2098923148 @default.
• W4281777887 cites W2105627261 @default.
• W4281777887 cites W2116475791 @default.
• W4281777887 cites W2116526419 @default.
• W4281777887 cites W2130312187 @default.
• W4281777887 cites W2136489990 @default.
• W4281777887 cites W2148773563 @default.
• W4281777887 cites W2152623033 @default.
• W4281777887 cites W2157823046 @default.
• W4281777887 cites W2165242637 @default.
• W4281777887 cites W2171916316 @default.
• W4281777887 cites W2283992568 @default.
• W4281777887 cites W2313548138 @default.
• W4281777887 cites W2320128544 @default.
• W4281777887 cites W2507872661 @default.
• W4281777887 cites W2519336182 @default.
• W4281777887 cites W2519940804 @default.
• W4281777887 cites W2560206254 @default.
• W4281777887 cites W2588681363 @default.
• W4281777887 cites W2750762793 @default.
• W4281777887 cites W2785704959 @default.
• W4281777887 cites W2792359759 @default.
• W4281777887 cites W2795780459 @default.
• W4281777887 cites W2811111349 @default.
• W4281777887 cites W2890093579 @default.
• W4281777887 cites W2902273797 @default.
• W4281777887 cites W2912110918 @default.
• W4281777887 cites W2914431396 @default.
• W4281777887 cites W2924769497 @default.
• W4281777887 cites W2946321184 @default.
• W4281777887 cites W2959714206 @default.
• W4281777887 cites W2965990610 @default.
• W4281777887 cites W3014410091 @default.
• W4281777887 cites W3023357416 @default.
• W4281777887 cites W3032421468 @default.
• W4281777887 cites W3082546321 @default.
• W4281777887 cites W3093204328 @default.
• W4281777887 cites W3098186837 @default.
• W4281777887 cites W3138885238 @default.
• W4281777887 cites W4300173333 @default.
• W4281777887 doi "https://doi.org/10.5152/anatoljcardiol.2022.1376" @default.
• W4281777887 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35703478" @default.
• W4281777887 hasPublicationYear "2022" @default.
• W4281777887 type Work @default.
• W4281777887 citedByCount "4" @default.
• W4281777887 countsByYear W42817778872022 @default.
• W4281777887 countsByYear W42817778872023 @default.
• W4281777887 crossrefType "journal-article" @default.
• W4281777887 hasAuthorship W4281777887A5029305216 @default.
• W4281777887 hasAuthorship W4281777887A5029711969 @default.
• W4281777887 hasAuthorship W4281777887A5044922060 @default.
• W4281777887 hasAuthorship W4281777887A5055814924 @default.
• W4281777887 hasAuthorship W4281777887A5059683450 @default.
• W4281777887 hasAuthorship W4281777887A5066222509 @default.
• W4281777887 hasAuthorship W4281777887A5075736599 @default.
• W4281777887 hasBestOaLocation W42817778872 @default.
• W4281777887 hasConcept C126322002 @default.
• W4281777887 hasConcept C127413603 @default.
• W4281777887 hasConcept C168563851 @default.
• W4281777887 hasConcept C207103383 @default.
• W4281777887 hasConcept C2776301958 @default.
• W4281777887 hasConcept C2776704044 @default.
• W4281777887 hasConcept C2778080469 @default.
• W4281777887 hasConcept C2779161974 @default.
• W4281777887 hasConcept C2780645631 @default.
• W4281777887 hasConcept C44249647 @default.
• W4281777887 hasConcept C71924100 @default.
• W4281777887 hasConcept C78519656 @default.
• W4281777887 hasConceptScore W4281777887C126322002 @default.
• W4281777887 hasConceptScore W4281777887C127413603 @default.
• W4281777887 hasConceptScore W4281777887C168563851 @default.
• W4281777887 hasConceptScore W4281777887C207103383 @default.
• W4281777887 hasConceptScore W4281777887C2776301958 @default.

• next